(19)
(11) EP 1 218 334 A1

(12)

(43) Date of publication:
03.07.2002 Bulletin 2002/27

(21) Application number: 00964535.9

(22) Date of filing: 06.10.2000
(51) International Patent Classification (IPC)7C07C 233/78, A61K 31/165, A61P 9/10, A61P 9/06
(86) International application number:
PCT/GB0003/847
(87) International publication number:
WO 0127/071 (19.04.2001 Gazette 2001/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 08.10.1999 GB 9923933

(71) Applicants:
  • SMITHKLINE BEECHAMLABORATOIRES PHARMACEUTIQUES
    92731 Nanterre CĂ©dex (FR)
  • SMITHKLINE BEECHAM PLC
    Brentford,Middlesex TW8 9EP (GB)

(72) Inventor:
  • BUSBY, DavidSmithKline Beecham Pharmaceuticals
    HarlowEssex CM19 5AW (GB)

(74) Representative: Rutter, Keith et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) POLYMORPHIC N-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]AMINO]PROPYL]- 4-NITRO BENZAMIDE HYDROCHLORIDE